JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Altered Cell to Cell Communication, Autophagy and Mitochondrial Dysfunction in a Model of Hepatocellular Carcinoma: Potential Protective Effects of Curcumin and Stem Cell Therapy
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Altered Cell to Cell Communication, Autophagy and Mitochondrial Dysfunction in a Model of Hepatocellular Carcinoma: Potential Protective Effects of Curcumin and Stem Cell Therapy
Tork, Ola M; Khaleel, Eman F; Abdelmaqsoud, Omnia M;
  PDF(new window)
 Abstract
Background: Hepato-carcinogenesis is multifaceted in its molecular aspects. Among the interplaying agents are altered gap junctions, the proteasome/autophagy system, and mitochondria. The present experimental study was designed to outline the roles of these players and to investigate the tumor suppressive effects of curcumin with or without mesenchymal stem cells (MSCs) in hepatocellular carcinoma (HCC). Materials and Methods: Adult female albino rats were divided into normal controls and animals with HCC induced by diethyl-nitrosamine (DENA) and . Additional groups treated after HCC induction were: Cur/HCC which received curcumin; MSCs/HCC which received MSCs; and Cur+MSCs/HCC which received both curcumin and MSCs. For all groups there were histopathological examination and assessment of gene expression of connexin43 (Cx43), ubiquitin ligase-E3 (UCP-3), the autophagy marker LC3 and coenzyme-Q10 (Mito.Q10) mRNA by real time, reverse transcription-polymerase chain reaction, along with measurement of LC3II/LC3I ratio for estimation of autophagosome formation in the rat liver tissue. In addition, the serum levels of ALT, AST and alpha fetoprotein (AFP), together with the proinflammatory cytokines and IL-6, were determined in all groups. Results: Histopathological examination of liver tissue from animals which received DENA- only revealed the presence of anaplastic carcinoma cells and macro-regenerative nodules. Administration of curcumin, MSCs; each alone or combined into rats after induction of HCC improved the histopathological picture. This was accompanied by significant reduction in -fetoprotein together with proinflammatory cytokines and significant decrease of various liver enzymes, in addition to upregulation of Cx43, UCP-3, LC3 and Mito.Q10 mRNA. Conclusions: Improvement of Cx43 expression, nonapoptotic cell death and mitochondrial function can repress tumor growth in HCC. Administration of curcumin and/or MSCs have tumor suppressive effects as they can target these mechanisms. However, further research is still needed to verify their effectiveness.
 Keywords
Connexin;gap junction;liver neoplasm;alpha fetoprotein;ubiquitin;
 Language
English
 Cited by
 References
1.
Abdel Aziz M, El Asmar M, Atta H, et al (2011). Efficacy of Mesenchymal Stem Cells in Suppression of Hepatocarcinorigenesis in Rats: Possible Role of Wnt Signaling. Journal of Experimental & Clinical Cancer Research, 30, 49 crossref(new window)

2.
Abdel Aziz M, Atta H, Mahfouz S, et al (2007). Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem, 40, 893-9 crossref(new window)

3.
Abdin A, Hamouda H ( 2008). Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenoneinduced parkinsonism. Neuropharmacol, 55, 1340-6 crossref(new window)

4.
Aita V, Liang X, Murty V, Pincus L, Yu W, Cayanis E, et al. (1999). Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics, 59, 59-65 crossref(new window)

5.
Balasubramanyam K, Varier R, Altaf M, et al (2004). Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyl transferase, represses the acetylation of histone/ nonhistone proteins and histone acetyl transferase-dependent chromatin transcription. J Biol Chem, 279, 51163-71 crossref(new window)

6.
Bassiouny A, Zaky A and Kandeel K (2011). Alteration of APendonuclease1 expression in curcumin-treated fibrotic rats. Ann Hepatol, 10, 516-530

7.
Boland M, Chourasia A and Macleod K (2013). Mitochondrial dysfunction in cancer. Front Oncol, 3, 1-28

8.
Bueler H (2010). Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease. Apoptosis, 15, 1336-53 crossref(new window)

9.
Cervello M, Montalto G. (2006), Cyclooxygenases in hepatocellular carcinoma. World J Gastroenterol, 12, 5113-21 crossref(new window)

10.
Cho K, Ju S, Cho S, et al (2009), Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow. Cell Biology International, 33, 772-7 crossref(new window)

11.
Dakshayani K, Subramanian P, Manivasagam T, et al (2005). Melatonin modulates the oxidant-antioxidant imbalance during N-nitrosodiethylamine induced hepatocarcinogenesis in rats. J Pharm Pharm Sci, 8, 316-21

12.
Darvesh A, Carroll R, Bishayee A, et al (2010). Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Exp Rev Neurother, 10, 729-745 crossref(new window)

13.
Ding Z, Shi Y, Zhou J, et al (2008). Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res, 68, 9167-75 crossref(new window)

14.
Forner A, Llovet J M, Bruix J. (2012). Hepatocellular carcinoma. Lancet, 379, 1245-55 crossref(new window)

15.
Fu Y, Zheng S, Lin J, et al (2008). Curcumin protects the rat liver from ccl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol, 73, 399-409

16.
Gao Z, Gammoh N, Wong PM, et al (2010). Processing of autophagic protein LC3 by the 20S proteasome. Autophagy, 6, 126-37 crossref(new window)

17.
Haybaeck J, Zeller N, Wolf MJ, et al (2009). A lymphotoxindriven pathway to Hepatocellular carcinoma. Cancer Cell, 16, 295-308 crossref(new window)

18.
Ionta M, Ferreira R, Pfister S, et al (2009). Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction. Cancer Cell Int, 9, 22 crossref(new window)

19.
Jankowska E, Stoj J, Karpowicz P, Osmulski P, et al (2013). The proteasome in health and disease. Curr Pharm Des, 19, 1010-28

20.
Kensler T, Quain G, Chen J, et al (2003). Translational strategies for cancer prevention in liver. J Natl Cancer Inst, 3, 321-9 crossref(new window)

21.
Khan N, and Mukhtar H (2015). Dietary agents for prevention and treatment of lung cancer. Cancer Letters, 395, 155-64

22.
Khedr N, Khedr E (2014). Antioxidant and Anti-inflammatory effects of curcumin on CCl4-induced liver fibrosis in rats. Am J Biomed Sci, 6, 191-200

23.
Kirkin V, McEwan D, Novak I, et al (2009). A role for ubiquitin in selective autophagy. Mol Cell, 34, 259-69 crossref(new window)

24.
Kojima T, Yamamoto M, Mochizuki C, et al (1997). Different changes in expression and function of connexin 26 and connexin 32 during DNA synthesis and redifferentiation in primary rat hepatocytes using a DMSO culture system. Hepatology, 26, 585-97 crossref(new window)

25.
Lee S, Lee J and Kim J (2012). Coenzyme Q10 increases the fatty acid oxidation through AMPK-mediated PPAR${\alpha}$ induction in 3 T3-L1 preadipocytes. Cell Signal, 24, 2329-36. crossref(new window)

26.
Liang X, Jackson S, Seaman M, et al (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 402, 672-6 crossref(new window)

27.
Liu J, Zhao H, Liu Y, et al (2012). Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats. J Trace Elem Med Biol, 26, 255-261 crossref(new window)

28.
Livak K and Schmittgen T (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT. METHODS, 25, 402-8 crossref(new window)

29.
Mathew R, Karantza-Wadsworth V and White E. (2007a). Role of autophagy in cancer. Nat Rev Cancer, 7, 961-7 crossref(new window)

30.
Mathew R, Kongara S, Beaudoin B, et al (2007b). Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev, 21, 1367-81 crossref(new window)

31.
Mesnil M, Crespin S, Avanzo J, et al (2005). Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta, 1719, 125-45 crossref(new window)

32.
Mizushima N (2007). Autophagy: process and function. Genes Dev, 21, 2861-73 crossref(new window)

33.
Nakamizo A, Marini F, Amano T, et al (2005). Human bone marrow derived mesenchymal stem cells in the treatment of gliomas. Cancer Res, 65, 3307-18 crossref(new window)

34.
Nishida M, Nishiumi S, Mizushina Y, et al (2010). Monoacetylcurcumin strongly regulates inflammatory responses through inhibition of NF-kappaB activation. Int J Mol Med, 25, 761-7

35.
Nyamandi VZ, Johnsen VL, Hughey CC, et al (2014). Enhanced stem cell engraftment and modulation of hepatic reactive oxygen species production in diet-induced obesity. Obesity (Silver Spring), 22, 721-9 crossref(new window)

36.
Packard R., and Libby P (2008). Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem, 54, 24-38

37.
Machado, C, Mendonca L, Venancio V, et al (2013). Coenzyme Q10 protects Pc12 cells from cisplatin-induced DNA damage and neurotoxicity. NeuroToxicology, 36, 10-16 crossref(new window)

38.
Qiao L, Xu Z, Zhao Z, et al (2008). Suppression of tumorigenesis by human Mesenchymal Stem Cells in a hepatoma model. Cell Res, 18, 500-7 crossref(new window)

39.
Rashmi R, Pillai SG, Vijayalingam S, et al (2008). BH3-only protein BIK induces caspase independent cell death with autophagic features in Bcl-2 null cells. Oncogene, 27, 1366-75 crossref(new window)

40.
Reuter S, Gupta S, Park B, et al (2011). Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr, 6, 93-108 crossref(new window)

41.
Sarkar F, Li Y,Wang Z, et al (2010). Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. Curr Pharm Des, 16, 1801-12 crossref(new window)

42.
Sherman M (2005). Hepatocellular carcinoma: epidemiology, risk factors and screening. Semin Liver Dis, 25, 143-154 crossref(new window)

43.
Shimizu K, Onishi M, Sugata E, et al (2007). Disturbance of DNA methylation patterns in the early phase of hepatocarcinogenesis induced by a choline-deficient L-amino acid-defi ned diet in rats. Cancer Sci, 98, 1318-22. crossref(new window)

44.
Sorokin A, Kim E and Ovchinnikov L (2009). Proteasome system of protein degradation and processing. Biochemistry (Mosc), 74, 1411-42 crossref(new window)

45.
Takahashi W, Watanabe E, Fujimura L, et al (2013): Kinetics and protective role of autophagy in a mouse cecal ligation and puncture-induced sepsis. Critical Care, 17, 160 crossref(new window)

46.
Ullah M and Khan M (2008). Food as Medicine: Potential therapeutic tendencies of plant derived polyphenolic compounds. Asian Pac J Cancer Prev, 9, 187-196

47.
Vara D, Salazar M, Olea-Herrero N, et al (2011). Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death and Differentiation, 18, 1099-1111 crossref(new window)

48.
Verfaillie T, Salazar M, Velasco G, et al (2010). Linking ER stress to autophagy: potential implications for cancer therapy [serial online]. Int J Cell Biol, 2010, 930509

49.
Yamasaki H and Naus C (1996). Role of connexin genes in growth control. Carcinogenesis, 17, 1199-213 crossref(new window)

50.
Yorimitsu T, Nair U, Yang Z, et al (2006). Endoplasmic reticulum stress triggers autophagy. J Biol Chem, 281, 30299-304 crossref(new window)